Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF.PK) today announced it will host a conference call for its Q1 2012 financial results and hold its Annual Meeting of Shareholders on Friday, May 4,...

Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF.PK) today announced that its partner, Medical Futures Inc. ("Medical Futures"), has launched Durela™ (extended-release tramadol) in Canada. The...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2011. Fiscal 2011 Summary Completed...

- Financial results to be released February 22, 2012 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 15, 2012 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) will host a conference call...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it reached a sales milestone for Lipofen®, the Company's fenofibrate product. This one-time milestone, which is based on sales...